BioVigil

BioVigil is a healthcare company founded in 2006 with a mission to combat Healthcare Associated Infections (HAIs) in hospitals, which are one of the Top 10 leading causes of death in the United States, contributing to over 75,000 preventable deaths annually. The company aims to provide superior infection control and disease mitigation solutions that enhance patient care environments. By focusing on this, BioVigil contributes to improving Patient Safety, Quality of Care, and Hospital Bottom Lines. Given the critical importance of the healthcare industry, particularly the urgent need for infection control solutions, BioVigil operates in the Health Care and Hospitality sectors. The company is based in the United States and received a significant Venture Round investment on 06 April 2022. The company has not disclosed the specific investors of this round. With its unique positioning and the emergence of healthcare challenges, BioVigil appears poised for potential growth as it continues to provide essential solutions to mitigate healthcare-associated infections.